>P42331_Disorder
5-10, 34-46, 84-91, 217-224, 355-375, 395-431, 499-518, 525-547
mslkLPRNWD fnlkveaaki arsrsvmtge qmaAFHPSST PNPLERpikm gwlkkqrsiv knwqqryfvl raqqlyyykd eedTKPQGCM Ylpgctikei atnpeeagkf vfeiipaswd qnrmgqdsyv lmassqaeme ewvkflrrva gtpcgvfgqr ldetvayeqk fgphlvpilv ekcaefileh grneegifrl pgqdnlvkql rdafdaGERP SFDRdtdvht vasllklylr dlpepvvpws qyegfllcgq ltnadeakaq qelmkqlsil prdnysllsy icrflheiql ncavnkmsvd nlatvigvnl irskvedpav imrgtpqiqr vmtmmirdhe vlfpKSKDIP LSPPAQKNDP KKAPVarssv gwdatedlri srtdSFSSMT SDSDTTSPTG QQPSDAFPED SSKVPREKPG Dwkmqsrkrt qtlpnrkcfl tsafqganss kmeifknefw spsseakage ghrrtmsqdl rqlsdsqrTS TYDNVPSLPG SPGEEASAls sqacDSKGDT LASPNSETGP GKKNSGEeei dslqrmvqel rkeietqkqm yeeqiknlek enydvwakvv rlneelekek kksaaleisl rnmersredv ekrnkaleee vkefvksmke pktea
>P42331_GlobDoms
2-354, 548-645
mSLKLPRNWD FNLKVEAAKI ARSRSVMTGE QMAAFHPSST PNPLERPIKM GWLKKQRSIV KNWQQRYFVL RAQQLYYYKD EEDTKPQGCM YLPGCTIKEI ATNPEEAGKF VFEIIPASWD QNRMGQDSYV LMASSQAEME EWVKFLRRVA GTPCGVFGQR LDETVAYEQK FGPHLVPILV EKCAEFILEH GRNEEGIFRL PGQDNLVKQL RDAFDAGERP SFDRDTDVHT VASLLKLYLR DLPEPVVPWS QYEGFLLCGQ LTNADEAKAQ QELMKQLSIL PRDNYSLLSY ICRFLHEIQL NCAVNKMSVD NLATVIGVNL IRSKVEDPAV IMRGTPQIQR VMTMMIRDHE VLFPkskdip lsppaqkndp kkapvarssv gwdatedlri srtdsfssmt sdsdttsptg qqpsdafped sskvprekpg dwkmqsrkrt qtlpnrkcfl tsafqganss kmeifknefw spsseakage ghrrtmsqdl rqlsdsqrts tydnvpslpg spgeeasals sqacdskgdt laspnsetgp gkknsgeEEI DSLQRMVQEL RKEIETQKQM YEEQIKNLEK ENYDVWAKVV RLNEELEKEK KKSAALEISL RNMERSREDV EKRNKALEEE VKEFVKSMKE PKTEA
JOB-ID: | P42331_015627Zzf7yn8AAAEAAF0HbGcAAAAT |
---|---|
Paramters: | propensities=Russell/Linding smooth=10 dy/dx_smooth=10 |
Disorder frames: | peak-frame=5 join-frame=4 |
Globularity frames: | peak-frame=74 join-frame=15 |
Name: | P42331 |
Description: | sp|P42331|RHG25_HUMAN Rho GTPase-activating protein 25 OS=Homo sapiens OX=9606 GN=ARHGAP25 PE=1 SV=2 |
Plot title/ID: | none |
Sequence length: | 645 |
Download Results | smoothed raw dydx |